Breaking the silence on liver myths: a call for evidence-based practice

Chronic liver disease (CLD) is increasingly prevalent and represents a major global health burden. Despite advances in diagnosis and management, both patients and non-hepatologist clinicians continue to hold misconceptions that adversely impact care quality and outcomes. Common myths include misunderstandings about the causes of liver disease, protein restriction in hepatic encephalopathy, and the risks of procedures like paracentesis. These beliefs often stem from limited hepatology exposure and unverified public health information. This narrative review identifies and categorises prevalent misconceptions in CLD, highlighting their real-world clinical consequences. By contrasting these myths with evidence-based guidance, we aim to promote awareness and improve multidisciplinary management. We advocate for targeted continuing medical education, structured care pathways, enhanced patient education and early transplant planning. Addressing these gaps is essential for delivering high-quality, equitable liver care and aligning clinical practice with current hepatology standards.